3-iodobenzylguanidine has been researched along with Arteriosclerosis, Coronary in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Awai, K; Fukuda, Y; Higashihara, T; Ikenaga, H; Ishibashi, K; Kurisu, S; Morita, Y; Nakano, Y; Nitta, K; Takahari, K; Takahashi, S; Takeda, A; Utsunomiya, H; Watanabe, N | 1 |
| Camargo, GC; de Almeida, SA; de Brito, ASX; de Holanda, MT; de Sousa, AS; Glavam, AP; Mendes, FSNS; Moll-Bernardes, RJ; Oliveira, RS; Pinheiro, MVT; Rosado-de-Castro, PH; Sangenis, LHC; Siqueira, FPR | 1 |
| Bokhari, S; Burg, M; Davidson, KW; Onyeji, I; Peacock, J; Whang, W | 1 |
| Bednarek-Skublewska, A; Chrapko, BE; Głowniak, A; Jaroszyński, AJ; Ksiażek, A; Załuska, W | 1 |
| Figueiredo, AB; Maciel, BC; Marin-Neto, JA; Miranda, CH; Simões, MV | 1 |
| Hartikainen, J; Hedman, A; Kuikka, J; Lehto, S; Simula, S; Vanninen, E | 1 |
| Beller, GA; Janardhanan, R | 1 |
| Tanaka, K | 1 |
| Gimelli, A; Giorgetti, A; Kusch, A; L'abbate, A; Marini, C; Marzullo, P; Sambuceti, G; Sereni, N | 1 |
| Endo, K; Hasegawa, A; Hatori, T; Kasama, S; Kurabayashi, M; Nakano, A; Suguta, M; Toyama, T | 1 |
| Agostini, D; Habraken, JB; Jacobson, AF; van Eck-Smit, BL; Verberne, HJ | 1 |
| Agostini, D; Banerjee, G; Burchert, W; Estorch, M; Jacobson, AF; Knuuti, J; Povinec, P; Sambuceti, G; Unlu, M; Verberne, HJ | 1 |
| Bax, JJ; Boogers, M; Henneman, MM | 1 |
2 review(s) available for 3-iodobenzylguanidine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Radionuclide imaging in stage B heart failure.
Topics: 3-Iodobenzylguanidine; Asymptomatic Diseases; Cardiomyopathies; Chronic Disease; Coronary Artery Disease; Glucose; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Prognosis; Radionuclide Ventriculography; Radiopharmaceuticals; Sarcoidosis; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2012 |
[I-123 metaiodobenzylguanidine myocardial images for assessment of coronary artery disease].
Topics: 3-Iodobenzylguanidine; Angina Pectoris; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Chest Pain; Coronary Artery Disease; Humans; Iodine Radioisotopes; Microvascular Angina; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Syndrome | 2003 |
2 trial(s) available for 3-iodobenzylguanidine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Iodine-123 metaiodobenzylguanidine myocardial imaging in haemodialysed patients asymptomatic for coronary artery disease: a preliminary report.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Asymptomatic Diseases; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Coronary Circulation; Humans; Kidney Failure, Chronic; Middle Aged; Myocardial Perfusion Imaging; Renal Dialysis; Sympathetic Nervous System | 2011 |
Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Cardiomyopathy, Dilated; Coronary Artery Disease; Heart; Heart Failure; Humans; Male; Myocardial Ischemia; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2005 |
9 other study(ies) available for 3-iodobenzylguanidine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Factors Influencing Cardiac Sympathetic Nervous Function in Patients With Severe Aortic Stenosis: Assessment by
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aortic Valve Stenosis; Coronary Artery Disease; Female; Heart; Humans; Iodine Radioisotopes; Male; Myocardial Perfusion Imaging; Sympathetic Nervous System | 2022 |
Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Autonomic Denervation; Chagas Cardiomyopathy; Chagas Disease; Contrast Media; Coronary Artery Disease; Death, Sudden, Cardiac; Fibrosis; Gadolinium; Humans; Myocardial Ischemia; Ventricular Premature Complexes | 2023 |
Antidepressant use is associated with reduced myocardial mIBG uptake in CAD patients.
Topics: 3-Iodobenzylguanidine; Aged; Antidepressive Agents; Coronary Artery Disease; Depression; Female; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2015 |
Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Chagas Disease; Coronary Artery Disease; Coronary Circulation; Echocardiography; Electrocardiography; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sympathectomy; Sympathetic Nervous System; Tachycardia, Ventricular | 2011 |
Myocardial (123) I-metaiodobenzylguanidine washout and heart rate variability in asymptomatic subjects.
Topics: 3-Iodobenzylguanidine; Coronary Artery Disease; Electrocardiography, Ambulatory; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2012 |
123I-MIBG imaging can be used to evaluate microvascular disturbance caused by embolization by microdebris after rotational atherectomy.
Topics: 3-Iodobenzylguanidine; Aged; Atherectomy, Coronary; Coronary Artery Disease; Embolism; Female; Humans; Male; Microcirculation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Mediastinum; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
Topics: 3-Iodobenzylguanidine; Coronary Artery Disease; Heart; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Ventricular Dysfunction, Left | 2008 |